Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

Author:

Giesen NicolaORCID,Sprute RosanneORCID,Rüthrich Maria,Khodamoradi Yascha,Mellinghoff Sibylle C.,Beutel Gernot,Lueck CatherinaORCID,Koldehoff Michael,Hentrich Marcus,Sandherr Michael,von Bergwelt-Baildon Michael,Wolf Hans-Heinrich,Hirsch Hans H.,Wörmann Bernhard,Cornely Oliver A.ORCID,Köhler PhilippORCID,Schalk Enrico,von Lilienfeld-Toal Marie

Funder

MSD

Roche

Pfizer

Karyopharm

University of Cologne

DMyKG

DZIF

Octapharma

GILEAD

MSD SHARP & DOHME

The German Federal Ministry of Health

Jazz Pharmaceuticals

NewConceptOncology

Neovii

Amgen

Janssen

Celgene

Sanofi

Takeda

German Federal Ministry of Research and Education

Deutsche Forschungsgemeinschaft

Actelion

Amplyx

Astellas

Basilea

Cidara

Da Volterra

F2G

Gilead

Melinta

Merck

Scynexis

Allecra

Biosys

Entasis

IQVIA

Matinas

MedPace

Menarini

Mylan

Nabriva

Noxxon

Paratek

PSI

Roche Diagnostics

Shionogi

Grupo Biotoscana

Miltenyi Biotec GmbH

Bergisch Gladbach

Chugai

Novartis

BMS

Medac

Oncopeptides

CDDF

DPharma

BMBF

Deutsche Jose Carreras Leukämie-Stiftung

IZKF Jena

DFG

Deutsche Krebshilfe

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3